Crossref DOIMemberCiteFactoropen accessissn
SJIF Impact Factor 8.659 | ISSN: 2582-3930
IJSREM Logo

International Journal of Scientific Research in Engineering and Management

(Gateway to Global Scholars - An International, Scholarly, Multi-Disciplinary, Open Access Journal)

Peer-Reviewed Journal Designed to Meet UGC's Quality Parameters

HomeCurrent IssuePast IssuesPay OnlineConferencesEditorial BoardAbout UsContact Us
IJSREM

Loading article...

Follow Us

  • Google Scholar
  • ResearchGate
  • Academia.edu
  • Mendeley
  • LinkedIn
  • Facebook
  • Instagram

Journal Policies

  • Peer Review Policy
  • Publication Ethics
  • Copyright Infringement
  • Refund & Cancellation Policy
  • Terms and Conditions
  • Privacy Policy

Journal Identifiers & Licenses

  • ISSN Verified: 2582-3930ISSN Verified: 2582-3930
  • Crossref DOI: 10.55041Crossref DOI: 10.55041
  • SJIF Ranking: 08.659SJIF Ranking: 08.659
  • Licensed under CC BY 4.0Licensed under CC BY 4.0
  • ISO Certification: 9001:2015ISO Certification: 9001:2015
  • Indexed & Cited In: Google ScholarIndexed & Cited In: Google Scholar

Contact Us

International Journal of Scientific Research in Engineering and Management (IJSREM)

#62/1, New No 7, 1st Cross, 2nd Main, Ganganagar, R T Nagar, Bangalore North, Bangalore, Karnataka, India – 560032
[email protected]+91 93911 67991
logos
logos
Working Hours

Mon – Sat: 9:00 AM – 6:00 PM

Sunday: 10:00 AM – 4:00 PM

+91 93911 67991

© 2026 IJSREM – International Journal of Scientific Research in Engineering and Management. This is an open-access journal. Articles are published under the Creative Commons Attribution (CC BY 4.0) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

DisclaimerPrivacy PolicyTerms and Conditions
ArticlePeer ReviewedOpen AccessPlagiarism Passed
Paper ID:IJSREM65071

Nanoparticle-Based Gel Delivery of Suzetrigine for Enhanced Pain Management

Stream/Area:

-

Subject:

-

Paper ID:

IJSREM65071

Volume:

10 |

6 |

Jun 2026

Pages:

1-4

Publication Frequency:

Monthly (12 issues per year)

DOI
Digital Object Identifier
10.55041/IJSREM65071

License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.

Share this article:

Authors

SB

Sakshi Bhogekar

Dept. of Pharmaceutics

Rajesh Bhaiyya Tope College of Pharmacy, Chh.Sambhajinagar.

Download Author Certificate
DSP

Dr. Santosh Payghan

Dept. of Pharmaceutics

Rajesh Bhaiyya Tope College of Pharmacy, Chh.Sambhajinagar.

Download Co-Author Certificate

Mentors

PAW

Prof. Amol Wadhave

Dept. of Pharmaceutics

Rajesh Bhaiyya Tope College of Pharmacy, Chh.Sambhajinagar.

Download Mentor Certificate

Author Services & Downloads

Full ArticlesAcceptance Certificate

Abstract

Suzetrigine is a novel, selective sodium channel (Naᵥ1.8) inhibitor developed for the management of moderate to severe pain, offering an effective non-opioid alternative for analgesia. Despite its promising pharmacological profile, conventional delivery of Suzetrigine may face challenges such as variable bioavailability, frequent dosing, and potential systemic side effects. To overcome these limitations, the present work focuses on the development of a novel drug delivery system (NDDS) for Suzetrigine aimed at enhancing therapeutic efficacy and patient compliance. The novel delivery approach is designed to provide controlled and targeted drug release, thereby maintaining optimal plasma drug concentrations over an extended period

KEYWORDS

Suzetrigine Analgesic Opioids Sodium channel blocker Opioid use disorder Novel analgesic

Cite This Article

Sakshi Bhogekar, Dr. Santosh Payghan, Prof. Amol Wadhave, "Nanoparticle-Based Gel Delivery of Suzetrigine for Enhanced Pain Management," International Journal of Scientific Research in Engineering and Management, vol. 10, no. 6, pp. 1-4, Jun 2026. https://doi.org/10.55041/IJSREM65071

Full Article/Conclusion

The present thesis organized a suzetrigine nanoparticle-based gel project into full academic format while preserving the uploaded Result and Discussion section as the core experimental chapter. The combined evidence shows that suzetrigine could be assessed analytically at 250 nm that the drug remained compatible with the main polymeric system on FTIR and DSC interpretation, and that physically acceptable gels with nanosized characteristics could be prepared. A second consideration is the relationship between material selection and patient-facing performance. A semisolid system can appear simple, but its final behavior depends on dispersion quality, polymer hydration, pH control, viscosity, release rate, and storage stability. When these factors are considered together, the dosage form becomes a structured platform for controlled delivery rather than a simple mixture of drug and excipients. The updated thesis presents a coherent project that begins with a current pain-management problem and ends with practical formulation recommendations.

References

1.                William B, Liechty NA. Expert opinion: Responsive polymers nanoparticles in cancer therapy. European Journal of Pharmaceutics. 2012;80:241-6. 2.                Nair B, Gjeure-Taylor R. A review of Topical Diclofenac use in Musculoskeletal Disease. Pharmaceuticals. 2010;3:1892-908. 3.                Elvira AC, Joseph Q, Rossend O. Assessment of diclofenac permeations with different formulations anti-inflammatory study of selected formula. Eur J Pharm Sci. 2003;19(4):203-10. 4.                Dua K, Pabrija K. Acelofenac Topical dosage forms; In vitro and in vivo characterization. Acta Pharm. 2010;60(4):467 5.                Jain H, Patel A, Gadiya S. In vitro release of diclofenac sodium from different topical vehicles, International. Journal Reseaech Pharma Sci. 2011;2(1):26. 6.                Nawaz A, Jan SU, Khan NR, Hussain A, Khan GM. Formulation and in vitro evaluation of clotrimazole gel containing almond oil and Tween 80 as penetration enhancer for topical application. Pak J Pharm Sci. 2013 May 1;26(3):617-22. 7.                Wani TU, Rashid M, Kumar M, Chaudhary S, Kumar P, Mishra N. Targeting Aspects of Nanogels: An Overview. International Journal of Pharmaceutical Sciences and Nanotechnology. 2014;7(4):2612-30. 8.                Neamtu I, Rusu AG, Diaconu A, Nita LE, Chiriac AP. Basic concepts and recent advances in nanogels as carriers for medical applications. Drug Delivery. 2017 Jan 1;24(1):539-57. 9.                Basha BN, Prakasam K, Goli D. Formulation and evaluation of gel containing fluconazole-antifungal agent. Int J Drug Dev Res. 2011 Oct;3(4):119-27. 10.             Leyva-GG, Piñón SE, Mendoza-MN, Zambrano-ZM, Mendoza-ES, Quintanar-GD. Approaches in Polymeric Nanoparticles for Vaginal Drug Delivery: A Review of the State of the Art. International journal of molecular sciences. 2018 May 23;19(6):1549.  

Editorial & Review Transparency

Publication Date

6/16/2026

Peer Review Type

Double-Blind Peer Review

Review Rounds: 2

Documents

Review Report (Confidential)
Copyright Form (Office)

Article Metrics & Impact

Article Views

0

Total views since publication

PDF Downloads

3

Total downloads since publication

Geographic Reach

5

Indexing, Archiving & Preservation

Google Scholar
Academia
ResearchGate
Crossref
SSRN
Semantic Scholar
Thomson Reuters
WorldCat
Mendeley
OpenAlex
EBSCO
Zenodo

Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.

Ethics, Compliance & Transparency

Plagiarism Screening

This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.

Conflict of Interest

The authors declare no conflict of interest related to this research work.

Funding Information

No funding information available for this research.

Similar & Recommended Articles

Similar Articles by Topic

Related research in the same subject area

Loading similar articles...